Does Kaiser Permanente Pay for GLP-1 Medications? (2026)
Kaiser Permanente covers GLP-1 medications only in limited cases; prior authorization is required, and members who are approved typically pay $10-$50 a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Where Each Medication Stands[5]
| Medication | What Kaiser does |
|---|---|
| Wegovy (semaglutide) | Per Kaiser Permanente's published 2026 Southern California Commercial HMO formulary and Northwest drug-specific monographs, Wegovy is restricted on Kaiser commercial formularies. Kaiser FEHB and PSHB plans place Zepbound on Tier 3/4 (specialty) with 50% coinsurance after PA and weight-management program participation. Kaiser added Wegovy for the cardiovascular-risk-reduction indication on supported plans. |
| Ozempic (semaglutide) | Covered for type 2 diabetes diagnosis through Kaiser pharmacy. |
| Zepbound (tirzepatide) | Limited. Available through Kaiser obesity-medicine programs in some regions under strict criteria (failed semaglutide trial, BMI thresholds). Kaiser FEHB/PSHB places Zepbound on Tier 3/4 with PA and weight-management program participation. |
| Mounjaro (tirzepatide) | Covered for type 2 diabetes; Kaiser providers typically prefer semaglutide first line. |
| Copay when it is covered | $10-$50 / month |
What a GLP-1 costs a Kaiser Permanente member
At Kaiser Permanente's typical copay of $10-$50 a month, a covered year of a GLP-1 costs $120 to $600. That is $3,588 to $4,068 less than a year of Wegovy bought for cash from NovoCare ($4,188), and Zepbound's LillyDirect price of $299 to $449 a month is further above it still.
No compounded seller beats a covered Kaiser fill: the cheapest, Collective at $59/mo, still costs $108 a year more than the top of the Kaiser range, so an approval is worth pursuing.
When Kaiser covers the drug, a manufacturer savings card can bring a Wegovy or Zepbound fill down to $25, with each maker paying at most $100 a month.
After a Denial from Kaiser Permanente
A Kaiser denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[3]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[4] cost far less than the brand; the cheapest sellers are listed below.
If a large employer self-funds your Kaiser plan, ERISA rather than state insurance law applies and the employer decides whether anti-obesity drugs are covered[2]; the Summary Plan Description says which.
Where to go if Kaiser Permanente says no
The 8 cheapest cash-pay compounded GLP-1s
| # | Seller | Monthly price | Score | Visit |
|---|---|---|---|---|
| 1 | Collective Compounded semaglutide | $59/mo | 8.4 | Visit |
| 2 | Boston Medical Group Compounded semaglutide | $66/mo | 5.9 | Visit |
| 3 | OurView Health Compounded semaglutide | $75/mo | 6.6 | Visit |
| 4 | Ivim Health Compounded semaglutide | $75/mo | 6.2 | Visit |
| 5 | Embody Compounded semaglutide | $79/mo | 9.3 | Visit |
| 6 | Lean Meds Compounded semaglutide | $79/mo | 9.3 | Visit |
| 7 | NextMeds Compounded semaglutide | $79/mo | 9.2 | Visit |
| 8 | NuuVim Compounded semaglutide | $79/mo | 7.7 | Visit |
Top-rated sellers that bill insurance
30 sellers say they accept insurance. Confirm with the seller that it bills Kaiser before you book.
| # | Seller | Cash price | Score | Visit |
|---|---|---|---|---|
| 1 | Shapely | $99/mo | 8.4 | Visit |
| 2 | Rivo Health | $149/mo | 8.2 | Visit |
| 3 | NovoCare Pharmacy | $149/mo | 7.9 | Visit |
| 4 | Cost Plus Drugs | $279/mo | 7.8 | Visit |
| 5 | Knownwell | $349/mo | 7.7 | Visit |
Every seller and price, side by side: compare all sellers.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Prior authorization (PA) · Insurance and regulatory
- Step therapy · Insurance and regulatory
- PBM (Pharmacy Benefit Manager) · insurance
- Formulary tier · Insurance and regulatory
- Copay accumulator · insurance
- Manufacturer coupon · insurance
- Quantity limit · insurance
Sources & methodology — as of September 2026
- 1.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
- 2.U.S. Department of Labor — ERISA and Employer Health Plans— U.S. Department of Labor, Employee Benefits Security Administration.
- 3.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 5.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.